We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 25, 2021

Adherence to Sacubitril/Valsartan After Hospitalization for HFrEF Is Associated With Improved Outcomes

JACC: Heart Failure


Additional Info

JACC: Heart Failure
Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
JACC Heart Fail 2021 Sep 01;[EPub Ahead of Print], AP Carnicelli, Z Li, MA Greiner, SJ Lippmann, SJ Greene, RJ Mentz, NC Hardy, V Blumer, X Shen, CW Yancy, PN Peterson, LA Allen, GC Fonarow, EC O'Brien

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading